NEOMYCIN TABLETS

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Compra

Foglio illustrativo Foglio illustrativo (PIL)
17-08-2016

Principio attivo:

NEOMYCIN SULFATE

Commercializzato da:

REKAH PHARMACEUTICAL INDUSTRY LTD, ISRAEL

Codice ATC:

A07AA01

Forma farmaceutica:

TABLETS

Composizione:

NEOMYCIN SULFATE 500 MG

Via di somministrazione:

PER OS

Tipo di ricetta:

Required

Prodotto da:

REKAH PHARMACEUTICAL INDUSTRY LTD, ISRAEL

Gruppo terapeutico:

NEOMYCIN

Area terapeutica:

NEOMYCIN

Indicazioni terapeutiche:

Diarrhea due to enteropathogenic escherichia coli. Supression of intestinal bacteria prior to intestinal surgery or as an adjunct in hepatic coma.

Data dell'autorizzazione:

2014-05-31

Foglio illustrativo

                                012345467894 9  4 64 6 4446
 !"#"$$%&'#
'#"$( !# #)"*+,-.,'#-$,"$(/
#$"'+ !$0,,"/1'&-.,)!
+$2., /+"113#
864
#$.")
56
789: ;<=>?@AB?BCDEAF8G?HII?: J
KLMNOPQKMONRSKNP
T$.$,$#."$!%
UV=<8DW?X9Y=C: ?XFAZ<[?\D;<9DAF8W?U8Z9B=D?]IIW?^ AJ>8B=C:
?XF8AZAF8W?_AD<
5 `6 466
abOcOdefONgehOQiMKjklmQQKMfOSeOROShi
5 464 6
a
8n<9D=
KfcOOkKOcOoNpKbOQqghMKbONemNmRKNelOSN
abOOpQKkejOhNKMhPMP
acRPMKjfOlrKOiKNmRKjQqghmKjQcqjKNmKbOqfQR
s9  649 8 9444 8
ckiNKeiKedKMleqjNKjemOgqKNpKtNKpecOKbiKedKMleqjRKmQjmMNKuOi
abOcOdefONgehOQiMKjklmQQKjqkiKMleqjNKjemOgqKjQOOfKbiKeiKvMOROPqQQ
abOOpQKjQOrkKNmKMqfQRKmQjmMNKuOi
aOpQRKjOjfNcKMNkQQKjwNRerKthOMKbiKedKMleqjRKmQjmMNKuOi
aueOqMRKthOMKbiKedKMleqjRKOmQjmjKNi
56`4  444664x6646849  649 8 944
aMfOhOQKthOMKbi
vujmMKjPqpQwMONPMKLcefljRKOefONQKqRpRKjNRrKeiKjwNRerKthOMKbi
bOqOqmKjmNekKvMpOQmMKvyrgMKOpQMKNmKjOROPKjfNcKuegPzKNePOpMKjPqpQ
auerhOfqlKjNkQKeiKyrORiqgKMOhjriOQzKMqeQk
5 6{4
ileqNKtPKNpKpOceMNKtONpKvOMmNPKMleqjNKeiKeMmNPKuedQNKMwmOgqKthOMKbi
aMleqjMKjNOShKOhlN
mOKMleqjMKjNOShKjlefjRKuPNKvbOqRepRKpeglNKNeNpKMleqjRKmeQOmM
acOQKileqNKOhlKvueOqMNKjrhPhKbiRKaMpOhQKOp|QiRKmeQOmKNpKcOlfMN
aileqKNmKRfpQRKjeOMNKmOKNelOSMKuQdR
5 6 6 564 666}
jqkiKMleqjRKNelOSKMjpKMdKjqQgKbiKeiKvjlrehKMleqjKjwNSehKthOMKbi
jeRegjQKbOpRehMKjeNOpOKOiKeiKbOhePOrKpehQNKOcPKNlSQMKileqNKkeecNKtONp
jlrehKMfOSeOROShiKLjeiRMKje|eRfMQKjeleqjKORgNKckeOQRKvjeOjleqjouOR
H7~IIU?I€I‚
vuOrfegOcKvcOQdeqelKvbOhONO|OhlMKeiKv
ƒn„
KuONO|OhlKvbOcOdefONgehOQiMKjklmQQ
auSqrRKNelOSNKjeleqjMQKfNkKvuOcQefKei
54664 66
jeplejKpOleMNKjeNeNpKMRKmeQOmMKuQdRKvMleqjMKNmKMOe|qMKjeNOplNK…rehR
jemqlMKeiKOeqOgKvNemNmKvMie|MKpR|RKOehOmKvMifMKvMNOkRKLuegPKvOieeN
ajeONihOge
T#+%$!#*%$$#'#"$$%!'$.#,#
ujmMKjNSMKjeqOcjRKeiKjeQPRKMjklMKvMQOmhKOOmfKvNemNmKvMpOQmRKOehOm
†cOQKileqNKOwMhleKNelOSMKjiKOwfrlMKLyqOchz
†cOQKileqNKOwMhleKNelOSRKOwtmQMKLyqOchzKMkOqlKvMmNek
NelOSMKjiKOwfrlMKLyqOchzK…eg
                                
                                Leggi il documento completo
                                
                            

Cerca alert relativi a questo prodotto

Visualizza cronologia documenti